4/A//SEC Filing
Schneider Joel Solomon Zev 4/A
Accession 0000899243-19-000973
CIK 0001707502other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:45 PM ET
Size
7.8 KB
Accession
0000899243-19-000973
Insider Transaction Report
Form 4/AAmended
Schneider Joel Solomon Zev
See Remarks
Transactions
- Sale
Common Stock
2018-11-15$31.10/sh−8,542$265,625→ 124,656 total - Sale
Common Stock
2018-11-15$30.68/sh−13,448$412,555→ 133,198 total
Footnotes (4)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
- [F4]Amendment corrects arithmetical error as to number of securities in Column 5 of Table I.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001727649
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:45 PM ET
- Size
- 7.8 KB